中/
繁/
EN

Diversified Businesses Park Operation

Park Operation

Park Operation

The comprehensive operation of an industry park involves land development, carrier construction, investment attraction, operations management, property service and commercial facilities. At the end of 2012, Dongguan City Biotech Industry Development Co., Ltd. was authorized by Dongguan Municipal People’s Government as the comprehensive operator of Cross-Straits Biotech Industry Cooperation Base. With a planned land area of 8,000 mu in Songshan Lake and townships of Dongguan, the Base is estimated to be invested with RMB 9.5 billion. As of the first half of 2017, the Base had been joined by 260 enterprises, including quality enterprises like HEC Pharm, 3Sbio Inc., Capital Genomics and Lifotronic. The Biotech Tower under construction covers a land area of 200 mu and is built for enterprise R&D and headquarters operations.
Cross-Straits Biotech Industry Cooperation Base

Demonstration Park

Cooperation base for biotechnology industry on both sides of the Taiwan Straits

A cluster of major biotech projects

A key demonstration zone of biotech development and industrialization

A major platform of biotech foreign cooperation

The biotech industry is a sunrise industry in the 21st century, the breakthroughs of which is generating a new round of industrial revolution. With vigorous support of the CPC Guangdong Provincial Committee and Guangdong Provincial People’s Government, the CPC Dongguan Municipal Committee and Dongguan Municipal People’s Government established the Cross-Straits Biotech Industry Cooperation Base in 2012. This strategic emerging industry has been prioritized to accelerate industry transformation and upgrade and build an innovative economy. The Cross-Straits Biotech Industry Cooperation Base is positioned as a cluster of major biotech projects, a key demonstration zone of biotech development and industrialization, a major platform of biotech foreign cooperation in Guangdong Province. With a planned land area of 8,200 mu and an investment of RMB 9.5 billion, the Base is marketized and comprehensively operated by the solely state-owned enterprise Dongguan City Biotech Industry Development Co., Ltd. Guided by a path of characteristic...